Anthropic says Claude has identified a previously uncharacterized enzyme system in bacteriophages, the viruses that infect bacteria. The company says the finding emerged from a new molecular-biology lab that combines Claude’s analysis of DNA data and scientific literature with experiments performed by its human researchers.
In its announcement, Anthropic says its scientists asked Claude to search a large DNA database for interesting reverse transcriptases, enzymes that copy RNA into DNA. The company says roughly 950 Claude agents worked through the data for 21 hours, using 210 million tokens, before one flagged an unusual repeating pattern of DNA next to a reverse-transcriptase gene.
What Anthropic says it found
Further analysis and laboratory testing led the team to what Anthropic calls array-associated reverse transcriptases, or ART. The underlying reverse transcriptase had appeared in earlier studies, the company says, but it says Claude was first to identify the combination of an associated array of non-coding DNA repeats and an additional protein whose role is not known.
That repeating structure is why Anthropic compares the discovery, cautiously, with CRISPR. CRISPR was first noticed as an unusual repeat sequence in bacterial DNA and became a foundation for gene-editing technologies. The comparison is about a structural resemblance and a research question, not proof that ART can be programmed or used for gene editing.
The result is an early one
Anthropic says its scientists reviewed Claude’s hypotheses and carried out all of the lab work. It has released a preprint describing the research, but says ART’s primary function remains unknown. The company also says it does not yet know whether the system could have uses similar to CRISPR.
That distinction matters because the reported result is a lead for further biology research, not a finished biotechnology tool. The clearest immediate claim is narrower: Anthropic says its researchers used a large group of AI agents to help spot a biological pattern worth testing, then validated part of that lead in the lab.
Sources: Anthropic’s announcement.